Peter Hoehn

Cohen Veterans Bioscience is a non-profit biomedical research and technology organization that focuses on advancing brain health by fast-tracking precision diagnostics and tailored therapeutics for the millions of veterans, service members, first responders, and civilians who suffer from brain trauma-related conditions such as PTSD and TBI. The American company leads a new approach to research, diagnosis, and treatment of these conditions.

Cohen Veterans Bioscience is a non-profit biomedical research and technology organization that focuses on advancing brain health by fast-tracking precision diagnostics and tailored therapeutics for the millions of veterans, service members, first responders, and civilians who suffer from brain trauma-related conditions such as PTSD and TBI. The American company leads a new approach to research, diagnosis, and treatment of these conditions.

Cohen Veterans Bioscience is a non-profit biomedical research and technology organization that focuses on advancing brain health by fast-tracking precision diagnostics and tailored therapeutics for the millions of veterans, service members, first responders, and civilians who suffer from brain trauma-related conditions such as PTSD and TBI. The American company leads a new approach to research, diagnosis, and treatment of these conditions.

Cohen Veterans Bioscience is a non-profit biomedical research and technology organization that focuses on advancing brain health by fast-tracking precision diagnostics and tailored therapeutics for the millions of veterans, service members, first responders, and civilians who suffer from brain trauma-related conditions such as PTSD and TBI. The American company leads a new approach to research, diagnosis, and treatment of these conditions.

Cohen Veterans Bioscience is a non-profit biomedical research and technology organization that focuses on advancing brain health by fast-tracking precision diagnostics and tailored therapeutics for the millions of veterans, service members, first responders, and civilians who suffer from brain trauma-related conditions such as PTSD and TBI. The American company leads a new approach to research, diagnosis, and treatment of these conditions.